Conference on Transparency and HCP Interaction by Informa Connect
In the rapidly evolving life sciences industry of 2025, regulatory changes are a constant, with increased government scrutiny and a push for regulatory clarity to balance patient protection with innovation. This complex landscape is marked by the rise of emerging technologies such as artificial intelligence (AI) in drug development, among other factors[1][3][5].
The upcoming Informa Connect's Transparency & HCP Engagement Conference offers an opportunity for insightful discussion on these topics. The event, scheduled for August 12, will run from 11:15am to 12:00pm[6].
Highlights of the conference include a session titled "Enforcement Update - Examining Today's Regulatory Landscape and Emerging Trends," which will be conducted by Amanda Masselam Strachan and Lauren Kootman, Principal Assistant Deputy Chief of the DOJ's Corporate Enforcement & Compliance Unit, Fraud Section[7]. This discussion will focus on HCP engagement, compliance monitoring, and data reporting and governance[8].
Amanda Masselam Strachan will also participate in a fireside chat on August 12, where she will delve into the current regulatory landscape and recent enforcement actions impacting the life sciences industry[9].
The conference brings together Pharma and MedTech visionaries for a day of insightful discussion[10]. It is organized by Informa Connect, a renowned organizer of events in the life sciences and healthcare sectors[4].
As the industry grapples with regulatory changes, particularly in the areas of AI, healthcare transactions, and drug manufacturing oversight[1][3][5], the conference aims to provide attendees with a comprehensive understanding of the latest guidance and expectations for effective compliance programs[2].
For those interested, more information about the conference can be found on the Informa Connect website[3]. In the face of ongoing regulatory changes, this event promises to be an invaluable resource for industry professionals seeking to stay ahead of the curve.
References:
- Regulatory Landscape in 2025
- Regulatory Guidance for Effective Compliance Programs
- Informa Connect's Transparency & HCP Engagement Conference
- About Informa Connect
- FDA Initiatives and Manufacturing Oversight
- Conference Schedule
- Lauren Kootman
- Session Topics
- Amanda Masselam Strachan
- The Informa Connect's Transparency & HCP Engagement Conference, focusing on topics like regulatory guidance for effective compliance programs, will provide a platform for insightful discussions about scientific advancements and their impact on medical-conditions, health-and-wellness, given the complex landscape of the life sciences industry in 2025.
- Attendees of the conference can look forward to sessions such as "Enforcement Update - Examining Today's Regulatory Landscape and Emerging Trends," which will delve into the current regulatory landscape and its influence on health-and-wellness, including medical-conditions and the use of technology like artificial intelligence (AI) in drug development.
